BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taylor B. Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences. World J Surg 2003;27:1249-57. [PMID: 14502404 DOI: 10.1007/s00268-003-7245-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Yoo J, Yan LH, Siddiqui AA. Can contrast harmonic endoscopic ultrasonography replace endoscopic ultrasonography-guided fine-needle aspiration in patients with solid pancreatic lesions? An American perspective. Endosc Ultrasound. 2017;6:1-3. [PMID: 28218193 DOI: 10.4103/2303-9027.190930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Sandblom G, Granroth S, Rasmussen IC. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. Ups J Med Sci. 2008;113:57-64. [PMID: 18521799 DOI: 10.3109/2000-1967-214] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
3 Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015;21:4323-33. [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
4 Kang KM, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions. Radiology. 2014;270:444-453. [PMID: 24126370 DOI: 10.1148/radiol.13122712] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 14.5] [Reference Citation Analysis]
5 Matsubara H, Itoh A, Kawashima H, Kasugai T, Ohno E, Ishikawa T, Itoh Y, Nakamura Y, Hiramatsu T, Nakamura M, Miyahara R, Ohmiya N, Ishigami M, Katano Y, Goto H, Hirooka Y. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases. Pancreas. 2011;40:1073-1079. [PMID: 21633317 DOI: 10.1097/mpa.0b013e31821f57b7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
6 Sonnenberg A, Rodriguez SA, Faigel DO. Diagnostic ascertainment of suspicious pancreatic mass: a threshold analysis. Clin Gastroenterol Hepatol 2008;6:1162-6. [PMID: 18928941 DOI: 10.1016/j.cgh.2008.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Friess H, Ho C, Kleeff J, Büchler M. Pancreaticoduodenectomy, Distal Pancreatectomy, Segmental Pancreatectomy, Total Pancreatectomy, and Transduodenal Resection of the Papilla of Vater. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 877-903. [DOI: 10.1016/b978-1-4160-3256-4.50068-5] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
8 Balthazar EJ. Pancreatitis associated with pancreatic carcinoma. Preoperative diagnosis: role of CT imaging in detection and evaluation. Pancreatology. 2005;5:330-344. [PMID: 16015017 DOI: 10.1159/000086868] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
9 Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006;12:246-50. [PMID: 16482625 DOI: 10.3748/wjg.v12.i2.246] [Cited by in CrossRef: 129] [Cited by in F6Publishing: 115] [Article Influence: 8.6] [Reference Citation Analysis]
10 Kirkegård J, Mortensen FV, Cronin-fenton D. Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. American Journal of Gastroenterology 2017;112:1366-72. [DOI: 10.1038/ajg.2017.218] [Cited by in Crossref: 141] [Cited by in F6Publishing: 111] [Article Influence: 35.3] [Reference Citation Analysis]
11 Resheq YJ, Quaas A, von Renteln D, Schramm C, Lohse AW, Lüth S. Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma. Dig Liver Dis 2013;45:859-65. [PMID: 23602806 DOI: 10.1016/j.dld.2013.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Sandrasegaran K, Nutakki K, Tahir B, Dhanabal A, Tann M, Cote GA. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer. AJR Am J Roentgenol. 2013;201:1002-1008. [PMID: 24147470 DOI: 10.2214/ajr.12.10170] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
13 Kim JH, Lee JM, Park JH, Kim SC, Joo I, Han JK, Choi BI. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study. Radiology. 2013;266:185-196. [PMID: 23192779 DOI: 10.1148/radiol.12120111] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
14 Krishnaraju VS, Kumar R, Mittal BR, Sharma V, Singh H, Nada R, Bal A, Rohilla M, Singh H, Rana SS. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue. Eur Radiol 2021;31:2199-208. [PMID: 33001304 DOI: 10.1007/s00330-020-07318-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gold DV, Gaedcke J, Ghadimi BM, Goggins M, Hruban RH, Liu M, Newsome G, Goldenberg DM. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma. Cancer 2013;119:522-8. [PMID: 22898932 DOI: 10.1002/cncr.27762] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kannengiesser K, Mahlke R, Petersen F, Peters A, Kucharzik T, Maaser C. Instant evaluation of contrast enhanced endoscopic ultrasound helps to differentiate various solid pancreatic lesions in daily routine. World J Clin Cases 2019;7:19-27. [PMID: 30637249 DOI: 10.12998/wjcc.v7.i1.19] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kersting S, Konopke R, Kersting F, Volk A, Distler M, Bergert H, Saeger HD, Grützmann R, Bunk A. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology. 2009;137:1903-1911. [PMID: 19715694 DOI: 10.1053/j.gastro.2009.08.049] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
18 Ma C, Li J, Boukar MB, Yang P, Wang L, Chen L, Su L, Qu J, Chen SY, Hao Q, Lu JP. Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis. Oncotarget 2017;8:99085-92. [PMID: 29228754 DOI: 10.18632/oncotarget.18457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Cruz-Monserrate Z, Qiu S, Evers BM, O’Connor KL. Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod Pathol. 2007;20:656-667. [PMID: 17415382 DOI: 10.1038/modpathol.3800782] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
20 Navarro S, Vaquero E, Maurel J, Bombí JA, De Juan C, Feliu J, Fernández Cruz L, Ginés À, Girela E, Rodríguez R, Sabater L. Recomendaciones para el diagnóstico, la estadificación y el tratamiento del cáncer de páncreas (parte I). Medicina Clínica 2010;134:643-55. [DOI: 10.1016/j.medcli.2009.12.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
21 Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest Endosc. 2009;70:70-79. [PMID: 19249774 DOI: 10.1016/j.gie.2008.10.030] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
22 Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol. 2006;24:252-258. [PMID: 16344318 DOI: 10.1200/jco.2005.02.8282] [Cited by in Crossref: 86] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
23 Dutta AK, Chacko A. Head mass in chronic pancreatitis: Inflammatory or malignant. World J Gastrointest Endosc 2015;7:258-64. [PMID: 25789097 DOI: 10.4253/wjge.v7.i3.258] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
24 Gonzalo-Marin J, Vila JJ, Perez-Miranda M. Role of endoscopic ultrasound in the diagnosis of pancreatic cancer. World J Gastrointest Oncol. 2014;6:360-368. [PMID: 25232461 DOI: 10.4251/wjgo.v6.i9.360] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
25 Hopt U, Keck T. [Pancreatic incidentalomas. Correct assessment and therapy]. Chirurg 2007;78:713-20. [PMID: 17628760 DOI: 10.1007/s00104-007-1373-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Moehler M, Galle PR, Kiesslich R. [Endosonography of the gastrointestinal tract]. Chirurg 2007;78:420-2, 424-7. [PMID: 17443300 DOI: 10.1007/s00104-007-1332-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Chu KE, Papouchado BG, Lane Z, Bronner MP. The role of Movat pentachrome stain and immunoglobulin G4 immunostaining in the diagnosis of autoimmune pancreatitis. Mod Pathol 2009;22:351-8. [DOI: 10.1038/modpathol.2008.196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
28 Badami S, Kyi HH, Upadhaya S, Al Hadidi S. Pancreatic Adenocarcinoma Masquerading as Idiopathic Chronic Pancreatitis with Delayed Diagnosis. Case Rep Oncol 2017;10:819-23. [PMID: 29070996 DOI: 10.1159/000480076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Shi C, Merchant N, Newsome G, Goldenberg DM, Gold DV. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Arch Pathol Lab Med. 2014;138:220-228. [PMID: 24476519 DOI: 10.5858/arpa.2013-0056-oa] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kirkegård J, Mortensen FV, Heide-Jørgensen U, Cronin-Fenton D. Predictors of underlying pancreatic cancer in patients with acute pancreatitis: a Danish nationwide cohort study. HPB (Oxford) 2020;22:553-62. [PMID: 31521499 DOI: 10.1016/j.hpb.2019.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Chou CY, Chang CT, Chen CJ. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry. Rapid Commun Mass Spectrom 2020;34 Suppl 1:e8580. [PMID: 31502717 DOI: 10.1002/rcm.8580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Szafranska-Schwarzbach AE, Adai AT, Lee LS, Conwell DL, Andruss BF. Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn. 2011;11:249-257. [PMID: 21463235 DOI: 10.1586/erm.11.10] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
33 Penheiter AR, Erdogan S, Murphy SJ, Hart SN, Felipe Lima J, Rakhshan Rohakhtar F, O'Brien DR, Bamlet WR, Wuertz RE, Smyrk TC, Couch FJ, Vasmatzis G, Bender CE, Carlson SK. Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma. Biomed Res Int 2015;2015:593572. [PMID: 26106611 DOI: 10.1155/2015/593572] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
34 Iglesias-Garcia J, Lindkvist B, Lariño-Noia J, Abdulkader-Nallib I, Dominguez-Muñoz JE. Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both? United European Gastroenterol J 2017;5:236-46. [PMID: 28344791 DOI: 10.1177/2050640616640635] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 7.6] [Reference Citation Analysis]
35 Xie J, Liu H, Liu WS, Li JW. Quantitative shear wave elastography for noninvasive assessment of solid pancreatic masses. Clin Hemorheol Microcirc. 2020;74:179-187. [PMID: 31476148 DOI: 10.3233/ch-190665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
36 Hocke M, Ignee A, Topalidis T, Stallmach A, Dietrich CF. Contrast-enhanced endosonographic Doppler spectrum analysis is helpful in discrimination between focal chronic pancreatitis and pancreatic cancer. Pancreas. 2007;35:286-288. [PMID: 17895854 DOI: 10.1097/mpa.0b013e318093f964] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 van der Gaag NA, Gouma DJ, van Gulik TM, Busch OR, Boermeester MA. Review article: Surgical management of chronic pancreatitis. Aliment Pharmacol Ther 2007;26 Suppl 2:221-32. [PMID: 18081665 DOI: 10.1111/j.1365-2036.2007.03486.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
38 Cho SG, Lee DH, Lee KY, Ji H, Lee KH, Ros PR, Suh CH. Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2005;29:163-169. [PMID: 15772531 DOI: 10.1097/01.rct.0000153956.33296.b5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
39 Drifka CR, Tod J, Loeffler AG, Liu Y, Thomas GJ, Eliceiri KW, Kao WJ. Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis. Mod Pathol 2015;28:1470-80. [DOI: 10.1038/modpathol.2015.97] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 11.7] [Reference Citation Analysis]
40 Tillou JD, Tatum JA, Jolissaint JS, Strand DS, Wang AY, Zaydfudim V, Adams RB, Brayman KL. Operative management of chronic pancreatitis: A review. Am J Surg 2017;214:347-57. [PMID: 28325588 DOI: 10.1016/j.amjsurg.2017.03.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
41 Hartmann D, Felix K, Ehmann M, Schnölzer M, Fiedler S, Bogumil R, Büchler M, Friess H. Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis. Pancreas. 2007;35:334-342. [PMID: 18090239 DOI: 10.1097/mpa.0b013e3180cac723] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
42 Isenmann R, Henne-bruns D. Indikationen zur chirurgischen Therapie benigner Pankreastumoren. Radiologe 2008;48:732-9. [DOI: 10.1007/s00117-008-1669-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]